2m 2m 2m 2m 2m 2m 2m
GEOVAX LABS (GOVX)
NASDAQ
$1.29+$0.0010 (+0.08%)
Price as of Jun 23, 2026 7:56 PM EDT- $6.9MMarket Cap
- -94.28%1-Year Change
- BiotechnologyIndustry
GEOVAX LABS (GOVX)
$1.29+$0.0010 (+0.08%)
GOVX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.29 | ||
Change | -$0.03 (-2.27%) | ||
Open | $1.27 | ||
High | $1.34 | ||
Low | $1.26 | ||
Previous Close | $1.32 | ||
Volume | 207,425 | ||
30-Day Average Volume | 1,342,083 | ||
1-Week Change | 10.26% | ||
1-Month Change | -64.56% | ||
1-Year Change | -94.28% | ||
3-Year Change | -99.42% | ||
5-Year Change | -99.93% | ||
Fundamentals | |||
Shares Outstanding | 5.2M | ||
Total Assets | $3.0M | ||
Market Cap | $6.9M | ||
Enterprise Value | $5.6M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$5.3M | ||
Free Cash Flow | -$3.5M | ||
EBIT | -$5.3M | ||
EBITDA | -$5.2M | ||
Net Working Capital | $139,783.00 | ||
EPS | -$2.62 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 14 | ||
P/E | -1 | ||
PEG | 0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 01/12/2026 | ||
Earnings & Revenue